MY173104A - Compounds from antrodia camphorata, method for preparing the same and use thereof - Google Patents
Compounds from antrodia camphorata, method for preparing the same and use thereofInfo
- Publication number
- MY173104A MY173104A MYPI2017702368A MYPI2017702368A MY173104A MY 173104 A MY173104 A MY 173104A MY PI2017702368 A MYPI2017702368 A MY PI2017702368A MY PI2017702368 A MYPI2017702368 A MY PI2017702368A MY 173104 A MY173104 A MY 173104A
- Authority
- MY
- Malaysia
- Prior art keywords
- compounds
- antrodia camphorata
- cancer
- preparing
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/21—Acetic acid esters of hydroxy compounds with more than three hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
- C07C49/577—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098177P | 2014-12-30 | 2014-12-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY173104A true MY173104A (en) | 2019-12-26 |
Family
ID=56163420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2017702368A MY173104A (en) | 2014-12-30 | 2015-12-30 | Compounds from antrodia camphorata, method for preparing the same and use thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9884801B2 (enExample) |
| EP (1) | EP3240772B1 (enExample) |
| JP (1) | JP6896630B2 (enExample) |
| CN (1) | CN105732381B (enExample) |
| ES (1) | ES2869904T3 (enExample) |
| MY (1) | MY173104A (enExample) |
| PL (1) | PL3240772T3 (enExample) |
| TW (1) | TWI648257B (enExample) |
| WO (1) | WO2016107582A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106063800B (zh) * | 2016-08-01 | 2020-02-18 | 上海交通大学 | 牛樟芝在抗前列腺增生药物中的应用 |
| ES2941463T3 (es) | 2016-11-18 | 2023-05-23 | Golden Biotechnology Corp | Composiciones para el tratamiento de la dermatitis atópica |
| CN108409571A (zh) * | 2018-03-23 | 2018-08-17 | 中国药科大学 | 从金刚纂中提取的用于治疗癌症的化合物 |
| WO2020176436A1 (en) * | 2019-02-25 | 2020-09-03 | Arjil Biotech Holding Company Limited | Method and composition for inhibiting virus infection |
| CN113831221B (zh) * | 2021-09-18 | 2023-04-07 | 云南民族大学 | 一种倍半萜类化合物及其制备方法与应用 |
| CN114487252B (zh) * | 2021-12-28 | 2024-03-26 | 陕西嘉禾生物科技股份有限公司 | 一种用于区别牛樟芝和牛樟木的薄层色谱鉴别方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6247838B1 (en) | 1998-11-24 | 2001-06-19 | The Boc Group, Inc. | Method for producing a liquid mixture having a predetermined concentration of a specified component |
| US7531627B2 (en) | 2003-12-19 | 2009-05-12 | Po-Jung Chien | Protein ACA1 of Antrodia camphorata |
| US7109232B2 (en) | 2004-03-08 | 2006-09-19 | Simpson Biotech Co., Ltd. | Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity |
| EP1634877B1 (en) | 2004-08-17 | 2011-06-22 | Simpson Biotech Co., Ltd. | Mixture and compounds from mycelia of antrodia camphorata and use thereof |
| US7601854B2 (en) | 2006-10-25 | 2009-10-13 | Kang Jian Biotech Corp., Ltd. | Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof |
| TW200829234A (en) * | 2007-01-08 | 2008-07-16 | Golden Biotechnology Corp | Antrodia camphorata isophorone extract |
| TW200918498A (en) * | 2007-10-19 | 2009-05-01 | Golden Biotechnology Corp | Novel compound isolated from Antrodia camphorate extracts |
| CN101417934B (zh) * | 2007-10-24 | 2012-04-18 | 国鼎生物科技股份有限公司 | 分离自牛樟芝萃取物的化合物 |
| TW201000112A (en) | 2008-06-18 | 2010-01-01 | Mackay Memorial Hospital | Use of dehydrosulphurenic acid for inhibiting the growth of cancer cells |
| US8309611B2 (en) * | 2010-09-20 | 2012-11-13 | Golden Biotechnology Corporation | Methods and compositions for treating lung cancer |
| CN103796647A (zh) * | 2011-06-10 | 2014-05-14 | 国鼎生物科技股份有限公司 | 用于治疗脑癌的方法和组合物 |
| CN103570531A (zh) * | 2012-07-25 | 2014-02-12 | 丽丰实业股份有限公司 | 樟芝菌丝体的化合物及其用途 |
| JP5908002B2 (ja) * | 2013-03-20 | 2016-04-26 | 卉菱 曽 | ベニクスノキタケに含まれる化合物及びその用途 |
| TWI583376B (zh) * | 2013-03-20 | 2017-05-21 | 曾卉菱 | Compounds isolated from Antelroxicus and their use |
| CN104177240B (zh) * | 2013-05-28 | 2016-10-19 | 曾卉菱 | 分离自牛樟芝的化合物、萃取物及其用途 |
| CN104211627A (zh) * | 2013-05-29 | 2014-12-17 | 曾卉菱 | 牛樟芝化合物、萃取物及其用途 |
| US9249117B2 (en) * | 2014-05-20 | 2016-02-02 | Hui Ling Tseng | Use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases |
-
2015
- 2015-12-30 PL PL15875258T patent/PL3240772T3/pl unknown
- 2015-12-30 TW TW104144385A patent/TWI648257B/zh active
- 2015-12-30 CN CN201511023602.XA patent/CN105732381B/zh active Active
- 2015-12-30 ES ES15875258T patent/ES2869904T3/es active Active
- 2015-12-30 MY MYPI2017702368A patent/MY173104A/en unknown
- 2015-12-30 EP EP15875258.4A patent/EP3240772B1/en active Active
- 2015-12-30 US US14/984,442 patent/US9884801B2/en active Active
- 2015-12-30 JP JP2017535086A patent/JP6896630B2/ja active Active
- 2015-12-30 WO PCT/CN2015/099894 patent/WO2016107582A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| TW201623208A (zh) | 2016-07-01 |
| JP6896630B2 (ja) | 2021-06-30 |
| EP3240772A1 (en) | 2017-11-08 |
| ES2869904T3 (es) | 2021-10-26 |
| US9884801B2 (en) | 2018-02-06 |
| US20160185703A1 (en) | 2016-06-30 |
| EP3240772B1 (en) | 2021-03-03 |
| CN105732381A (zh) | 2016-07-06 |
| JP2018507175A (ja) | 2018-03-15 |
| EP3240772A4 (en) | 2018-08-29 |
| CN105732381B (zh) | 2021-07-20 |
| PL3240772T3 (pl) | 2021-06-28 |
| WO2016107582A1 (en) | 2016-07-07 |
| TWI648257B (zh) | 2019-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201906111B (en) | Cyclic di-nucleotides compounds for the treatment of cancer | |
| PH12019501959A1 (en) | Therapeutic rna | |
| EA201892486A1 (ru) | Способ получения соединения диарилтиогидантоина | |
| MX2019002356A (es) | Compuestos de biarilo utiles como inmunomoduladores. | |
| EA201791208A1 (ru) | Антитела к cd38 для лечения острого миелолейкоза | |
| EA201890131A1 (ru) | Иммуномодуляция и лечение солидных опухолей антителами, которые специфически связывают cd38 | |
| ECSP17005635A (es) | Inhibidores de desmetilasa-1 específica a lisina | |
| MX2017004715A (es) | Anticuerpos anti-ox40 humanizados y usos de los mismos. | |
| EA201691857A1 (ru) | Соединения, применимые в качестве иммуномодуляторов | |
| MX2016016881A (es) | Anticuerpos que se unen a axl. | |
| MY173104A (en) | Compounds from antrodia camphorata, method for preparing the same and use thereof | |
| PH12017501151A1 (en) | Processes for the preparation of a diarylthiohydantoin compound | |
| PH12017500853A1 (en) | Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases | |
| IN2015CH01182A (enExample) | ||
| SG10201908248PA (en) | Processes for preparing fluoroketolides | |
| PH12017501872A1 (en) | Methods of treating diseases | |
| EP3969001A4 (en) | BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR THE TREATMENT OF NOTCH-ACTIVATED BREAST CANCER | |
| MX2019002017A (es) | Derivados de sofosbuvir para el tratamiento de la hepatitis c. | |
| PH12017501869A1 (en) | (s)-2'-vinyl-abscisic acid derivatives | |
| EP3389670A4 (en) | METHODS OF TREATING BREAST CANCER | |
| GB2564185A (en) | Process for the preparation of derivatives of benzodioxole | |
| PH12016502592A1 (en) | 3'-substituted-abscisic acid derivatives | |
| PH12018502377B1 (en) | Process for the manufacture of 6-alkynyl-pyridine derivatives | |
| IN2014DE00554A (enExample) | ||
| EA201992022A1 (ru) | Терапевтическая рнк |